Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03329300 · ClinicalTrials.gov registry record · NA
Cognitive Aspects of Response to Treatment for Weight-related Health to Improve Eating and Exercise Earlier in Life
A NA study of Pediatric Obesity and Executive Function, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT03329300: Completed NA study of Pediatric Obesity and Executive Function, sponsored by University of Alabama at Birmingham.
NCT03329300 is a NA study of Pediatric Obesity and Executive Function that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 34 participants, below the 229-participant average among 45 other Pediatric Obesity trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03329300, a NA study of Pediatric Obesity and Executive Function, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
We plan to examine whether child and parental cognitive/executive function predict body composition outcomes and adherence to a 6-month protocol of Family-Based Behavioral Treatment (FBT), for pediatric obesity. Our objectives are to: (1) examine the effects of parent and child complex cognitive functions on treatment outcomes and adherence in a 6-month FBT program for obesity in a diverse group of children aged 8-12 (total of 16 child-parent pairs), and (2) examine the strength of the relationship between parent and child cognitive function. We hypothesize that children with poorer executive function, and those who have parents with poorer executive function, will have poorer body composition and adherence outcomes.
Primary Outcome
Dual-energy X-ray Absorptiometry (DXA)
Conditions Studied
Interventions
- BEHAVIORAL Family-based Behavioral Treatment (FBT)
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2018-06-04 |
| Est. Completion | 2019-02-28 |
| Phase | NA |
What the finished NCT03329300 record still lists
NCT03329300 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 229-participant average among 45 other Pediatric Obesity trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Pediatric Obesity appearing as the primary indexed condition, and to 1 intervention - of which Family-based Behavioral Treatment (FBT) is the first listed.
NCT03329300 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT03329300 about?
NCT03329300 is a clinical study titled "Cognitive Aspects of Response to Treatment for Weight-related Health to Improve Eating and Exercise Earlier in Life". We plan to examine whether child and parental cognitive/executive function predict body composition outcomes and adherence to a 6-month protocol of Family-Based Behavioral Treatment (FBT), for pediatric obesity. Our objectives are to: (1) examine the effects of parent and child complex cognitive fun...
What is the current status of trial NCT03329300?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2018-06-04. Estimated completion is 2019-02-28.
What conditions does trial NCT03329300 study?
This clinical trial studies the following conditions: Pediatric Obesity, Executive Function.
What interventions are being tested in trial NCT03329300?
The interventions under investigation include: Family-based Behavioral Treatment (FBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03329300?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03329300 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03329300's enrollment target sits among peer trials
34 37th of 45 higher than 9 of 45 other Pediatric Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
RECRUITING · NA
-
iAmHealthy Clinical Practice Guideline (CPG)
RECRUITING · NA
-
Monitoring Eating Across Locations (MEAL) - Timing, Intake, and Mealtime Evaluation (TIME)
RECRUITING · NA
-
Nutrition and Obesity in Under-Represented Populations: Food Insecurity Research to Advance Science and Improve Health
RECRUITING · NA
-
Growing Healthy Children and Families in Rural Arkansas
RECRUITING · NA
-
Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI